An interventional study of multi-modal non-pharmacological intervention in Dementia, sponsored by Taipei Medical University Shuang Ho Hospital. Recruiting at 1 site in Taiwan. Open to participants aged 60 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-10-28.
Sponsored by Taipei Medical University Shuang Ho Hospital · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 105 studies in Dementia with a site in Taiwan — 23 open to participants now, 28 under way, 1 of them phase 3. Dementia · Taiwan.
Among the 105 studies in Dementia with a site in Taiwan, this one is the 9th largest by planned enrollment of the 84 interventional ones that give a count, is one of 12 that started in 2022, is one of 66 with no phase, reaches primary completion later than 12 of the 27 other live ones, and was the 54th registered.
2,377 studies on the registry are indexed under Dementia; 572 are open to participants now.
Browse Dementia studies →23 of the 105 studies in Dementia with a site in Taiwan are open now. Recruiting first, the newest first:
Chang Gung Memorial Hospital · Sites in Taiwan
Ages 40+ · Healthy volunteers
Lotung Poh-Ai Hospital · Sites in Taiwan
Ages 20–90
Stichting International Registry for Alzheimer's Disease and other Dementias Foundation · Sites in Taiwan, Australia, Austria and 14 more countries
Ages 18+
Fu Jen Catholic University · Sites in Taiwan
Ages 60–85 · Healthy volunteers
Mackay Medical College · Sites in Taiwan
Ages 65–110
A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →
Of the 382 Dementia studies recruiting now, 242 (63%) set no upper age limit and 25 (7%) stop at 75 or younger; 15 take children under 18; 163 take healthy volunteers.
This study: 60 Years to 90 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
105 studies; the count open now beside each. This study's row is marked.
First in 2002; this study’s year is marked. 12 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 380 is above the median of 90 across 1,761 interventional studies indexed under Dementia.
Median enrollment 100 across the 84 interventional studies, 225 across the 20 observational. Of the 54 that completed or were terminated, 4 (7%) have results posted.
This tab as a report to print or save as PDF → With an account.
8 of 105 have an industry lead sponsor. The 10 most frequent:
Taipei Medical University Shuang Ho Hospital is the lead sponsor of 102 studies on the registry; 18 are open to participants now.
Taipei Medical University Shuang Ho Hospital has 6 studies filed under Dementia — fewer than ten, so there is no comparison to draw.
7 of the studies in Dementia with a site in Taiwan that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06198699National Cheng Kung UniversityEffects of Jing Si Herbal Tea on Quality of Life and Sleep in Dementia and Their Caregivers | 2026-12 |
| NCT05407857Taipei Medical University Shuang Ho HospitalTaiwan Geriatric Study for Dementia Risk Prevention and Cognitive Enhancement by Multi-modal Intervention | 2026-12 |
| NCT07041034Mackay Medical CollegeSUNAM Protocol for Managing BPSD | 2026-12-30 |
| NCT06854497Chiayi Christian HospitalThe Impact of Non-motor Symptom on the Outcome of Stroke Subjects | 2026-12-31 |
| NCT07458620Chang Gung Memorial HospitalProspective Single-Arm Safety Study of Cervical LVA in AD Patients | 2027-05 |
Add all 7 to your calendar (.ics) → With an account.
Among the 105 studies in Dementia with a site in Taiwan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
A 3-arm randomized controlled trial of multi-modal non-pharmacological Intervention for preventing the risk of dementia in Taiwanese geriatric people
This project proposes an intervention program for dementia prevention based on the Taiwanese model. The investigator(s) will screen the elderly who are not yet demented but are at high risk of dementia and will randomly allocate them into three groups (on site intervention group, remote intervention group, and control group) for a two-year multi-modal non-pharmacological intervention. All intervention groups will be actively involved in management with nutrition, exercise and cognitive programs. The on-site intervention group requires subjects to participate in prescribed place according to the protocol. The remote intervention group is designed for reducing the chances of person-to-person contact response to the current coronavirus disease 2019 (COVID-19) pandemic and development of digital internet. It uses innovative technology combining wearable devices with inertial measurement units, blue-tooth equipment, apps, feedback technology and artificial intelligence based remote comprehensive training programs. During the study period, each group will be regularly monitored the changes of cardiovascular risk factors, physical performance and cognitive function. The results of multimodal intervention mainly from Taipei and New Taipei City will establish the Taiwan FINGER model (TaiPEI) and will have the information of the conditions and feasibility achieved in Taiwan and implementation suggestions in the face of the epidemic. It can be subsequently applied to the brain/body health care institution and to the prevention of dementia and cardiovascular disease of elderly.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The on-site multi-modal intervention will be actively involved in management with nutrition, exercise and cognitive programs. The on-site intervention group requires subjects to participate in prescribed place according to the protocol.
Behavioral: multi-modal non-pharmacological intervention
The remote intervention group is designed for reducing the chances of person-to-person contact response to the current COVID-19 pandemic and development of digital internet. It uses innovative technology combining wearable devices with inertial measurement units, blue-tooth equipment, apps, feedback technology and artificial intelligence based remote comprehensive training programs.
Behavioral: multi-modal non-pharmacological intervention
The control group will also receive the same health evaluation and education as all intervention groups.
Behavioral: multi-modal non-pharmacological intervention
multi-modal non-pharmacological intervention including the management with nutrition, exercise and cognitive programs
Change in cognition including individual cognitive domains, unit on a scale
A composite z-score will be obtained from the neuropsychological tests evaluating multiple cognitive domains, including memory, language, process speed, visuospatial, and executive function.
Time frame: Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Change in physical assessment, unit on a scale
Senior Fitness Test (SFT) measures six functional areas of physical function (strength, endurance, balance, agility, and flexibility)
Time frame: Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Change in physical assessment, unit on a scale
Short Physical Performance Battery (SPPB), score range: 0-12; higher scores mean a better outcome.
Time frame: Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Change in physical assessment, unit on a scale
International Physical Activity Questionnaire (IPAQ), a 27-item self-reported measure of physical activity
Time frame: Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Change in physical functioning - Hand-grip strength, kg
Measured using a hand-grip dynamometer
Time frame: Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Change of the questionnaire regarding the nutrition, unit on a scale
Mini Nutritional Assessment-Short Form (MNA-SF), a screening scale used to assess current nutritional status. score range: 0-14, higher scores mean a better outcome.
Time frame: Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Change of the questionnaire regarding the nutrition, unit on a scale
food frequency questionnaire (FFQ), a finite list of foods and beverages with response categories to indicate usual frequency of consumption over the time period
Time frame: Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Change of nutrition intake, unit on a scale
3-day dietary record: a self-reported account of all foods and beverages consumed within recent three days
Time frame: Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Change in functioning level, unit on a scale
Activities of Daily Living Questionnaire (ADLQ)
Time frame: Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Change in functioning level, unit on a scale
The Brief University of California San Diego (UCSD) Performance-Based Skills Assessment (UPSA-Brief) -Traditional Chinese Version: two subdomains (Finances, Communication) with a total score ranging from 0 to 100.
Time frame: Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Change in functioning level, unit on a scale
Florida Cognitive Activities Scale (FCAS): a 25-item scale used to assess cognitive activities in the elderly with two subscales (Higher Cognitive Abilities and Frequent Cognitive Abilities)
Time frame: Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Change in functioning level, unit on a scale
EuroQol five-dimensional (EQ-5D): an instrument for measuring quality of life regarding the five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.
Time frame: Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Change in functioning level, unit on a scale
Activities of Daily Living Questionnaire (ADLQ), The Brief University of California San Diego (UCSD) Performance-Based Skills Assessment(Traditional Chinese Version)(UPSA-Brief), Florida Cognitive Activities Scale(FCAS), EuroQol five-dimensional (EQ-5D)
Time frame: Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Change in depressive symptoms, unit on a scale.
Geriatric Depression Scale-Short Form (GDS-S), score range: 0-15; higher scores mean a worse outcome.
Time frame: Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Change in sleep symptoms, unit on a scale.
Epworth sleepiness scale (ESS)
Time frame: Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Change in sleep symptoms, unit on a scale.
Pittsburgh Sleep Quality Index (PSQI)
Time frame: Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Change in blood tests - fasting plasma glucose, mmol/L.
Measured from fasting blood sample
Time frame: Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Change in blood tests - triglycerides, mmol/L.
Measured from fasting blood sample
Time frame: Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Change in blood tests - Albumin, prealbumin, g/dL.
Measured from fasting blood sample
Time frame: Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Change of Plasma amyloid beta, pg/mL
Assessed by ultra-sensitive, immunomagnetic reduction assay (MagQu, LLC, Surprise, AZ),
Time frame: Before intervention (Baseline); During intervention (6th month and 24th month)
Change of Plasma tau, pg/mL
Assessed by ultra-sensitive, immunomagnetic reduction assay (MagQu, LLC, Surprise, AZ),
Time frame: Before intervention (Baseline); During intervention (6th month and 24th month)
Started Jul 2022 (actual). Primary completion is estimated for Dec 2026, 53 months after the start.
Of 862 non-industry interventional studies with no phase under Dementia, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 53 months is above that.
Counting every sponsor, half of 908 studies reached it within 25 months; a quarter within 11 and three quarters within 43.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Taipei Medical University Shuang Ho Hospital →